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va~ Of Ihe LVMI ar~l extent of LVH in ix~e~s Mth HCM. "1~,  
~.~-~- ;~1 ACE genotyp~  f~r 5.4, and 10o1% of lhe v 'ad~ of 
LVMI m-d extent Of hypertrophy. Neither AGT genotYpe~ (T174M asd M~51") 
nor AT IIFla g~otypes had any in l lu~ on LVMI ;~nd s~me of Izypeflrol~. 
TII~, gender and AGE genotyp~ account f~' a frax~on of tl'~ v'miabTdy Of 
tl~ i~ l~ io  ~ of LVH in pafle~ with HOM. The greatef mag- 
dtude Of ~ in male ~ r~s ~-,;~-.)s1~ ~ Previous 
repolts have Shown !~n male patierds w~th HCM m v,u-~ I~  ~o be victim 
Of s~, .~ 0argo e~th t~_.n fen'k~eS. Our resu~ ~ that g',e repo~ 
Idgher Inc~ler,~ of sud~ can~ de~ In male pUlents Is due In pan ~ two 
gen~ f'a~m: male gender and ACE genolype. Mulati~ causi~ HCM 
~ wi~ ~ e~t~mive ,~-~:.~lar hyp~rophy when it occu~ 
in t~  male as ~ ~o female gender. The ,~,-,,,~,~m of mate gentler 
and b'le ACE genotype DO mw pm~;p~ to a hi~l~e~ inckk~ of ~mdden 
car~ de~h In HCM. 
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Tev~ Aoyagt, Ya~-unob~ Hirata, 8htn-ichi Momomura, ~ Pedasamy. 
The ~ ~ ret~utum C.~+Al-Pase (SERCA2) ~ and 
mRNA were known to be ~- ,~;ed  in mm~y I~l~ogical ~ua~ions tch 
s ~  of SERC, A2 are yet to be i ~  espe~ in in vivo se1~ 
ir~o a felt ven'idcular pex of ~'~It rat basils. T ~  leve~ of SERCA2 
was evat,ated by L,c assay in myocar~ Um~e ~ .  Trars~ Of- 
~-y  vm e~n~d by t~ expess~ of ~n j~ed ~o,s t~y a~e 
p.gal gene. First. we ir~e~ed the (:onstnx~ *1110Lu~ conr~¢~ of -1110t~ 
upstream region of SERCA2 promoter and Luc reporter. ~ Luc a~ 
~vitywas 256 :E 119~. 44 ~- 26~,40 ~:8',31 :E 15", 13 ~ P; time~ l~her 
~ ~  at I, 2. 3. 4 and 5~,~ ~e~ me ~N, ,  ~ ,m~y.  
' I~  mqxesslon of ~oas'tru~ wlt~ ~ns  in 6ERCA~ ~ -.6~Luc, 
~Luc  -~TLuc, -7'~.ue were examined or~ week a~er the ~ Luc 
ac~y v~e Sl ..'- . * ,  ~,4 -~ s~, 2o .  ~, a.d 0.OS .-'- 0.0t§ fords o~ maz ~ 
-11101.~injected rats, ~ .  tn compensa~ 10msste~e-ovedo~ hy- 
per t~ induced by g~e DOCA-s~t method, my~ar~ exp , -~ ~f t~ 
.1110t~ constnx:t was siam'far ('/5.2%) to 8~at in Sham controls at o~e week. 
In co~'~ast, a severe ~ m~,~ ban~ (mean pressure grad~e~ 88 
rr~lg , .~  a ,esme~ mortarny: 40%) ~ ~ ,;e~,~ed ~, -~ 
(35.7%* of Slzan controls) at one week. Thus, the ,~x~,st~n of SERCA2 
pramwr inJec~ in vivo was ~ in compensated ~ .  ~ 
de~ irl sevem ~ ~-~:~e-ovedoa~ (§ p < 0.05,'p < 
0.0;) 
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Sedal EchocardlograpMc ~ of Left 
Ventrieulsr Funetlon and Ge~e AnMyMs of 
~ Prollein and Cc~agen A f t~ ~ i a l  
Aklh~sa ~ i ,  Minoru Yoshlyama, Iku Toda, l<~mame 
Masakazu Terdgakl. Kazullide Takeu~, Jyl~Ud YoShikawa. F~t 
The f :~  Of this study were to assess Ihe elfe~t of ~ n  II lype 
1 recepto~ antagonist (TCV.116; t0 n~kO/day) on left verdficul~" func~on 
by us~g ~ and t~ anatyz~ gene ~. , -~~ of contract, e 
prote~ asd ~ogage~ t,mo~," an~- myocan~ ~ Myo~,d~ Infam- 
tion was made by llgal}on of comna~ arlely In Wistar rats and TG'V+t16 was 
admlnisten~ after su~geeJo On 1, 2 and 3 weeks after ~ krdan:~'0a. 
left ventdcu~ geomeW was measured and mRNAs In canJiac I~sue were 
LV er,~amr¢ ~ (LVOd) and ~ sho~m~ (FS) 
on I week were 9.1 ~ 0.6 mm al'¢116 ~ 4%, n~ec6~/ ,  and LVDd on 3 
weeks IncreaSed ~ 11.1:1:0.8 (p < 0.0b') ard F~ d~n~U~ to 11.5 • 5% 
(p < 0,01). TCV-116 IXeV~-i;~ an increase of LVEDV (92 ~- 0.5 ram; p < 
0.01) and ~ FS (17 :t= 5%; p < 0,01) on 3 wee~ ~le leR verdlk:ular 
u~t  ~,,If~,~y ~ ~ 3 we~s ~ n~,~'~,a~ infar~on (2.41 • 
0.0~ ~) .  ~h w~ ~ by T~Vm6 ~ ~ ± 0.~ g~g;P 
um~ I ~  (ANP), ~ growth f"dCt~ (TGF)-~I, collage~ types I, 
lit, IV, and matrf~ n ~  (MMP).2 in 1he ~ lefl venblc- 
ular ~ ~ by 3.0-, 6.7-, 1.6-, 7.9-, 4.t-, 2.t~. stud 1A-fold on 
1 waek, respectiv~ (p < 0.01). a-~o~Sal ac~in mRNA i r~,~ l  on 3 wee ks 
by ~.gjou (p < o.01), TCV-I~S si~i~ar~y ~ ma im~a~ 0ene 
expmsdons of p-MHC, ~-skeletal c~n asd ANR On tile oltter Iland, TGF-pl, 
6br0rmC~, CxzgaQen I, III, IV, and MMP-2 mRNAs In the ischee~ region ~g- 
nificangy increased by 6.6,12.0, 26.2., 12.7. 5.6,, and P..2~old, respe~ively. 
TCV-t16 o~d not affect TGF-pl, fi~mec~, and collagen I, HI, iV h~RNAs 
in ischen~ a.,xl noetschemlc reg~ocs However, it increased MMP-2 mRNAs 
on 1 week ~ both ~,gions. In conduston, TCV-116 prevented ~ 
file change of the ~-~as  of cordractile Ixotetn. TCV-116 acceleva~ 
g',e gene expmsslon Of MMP-~ which may be con~ted to prevent can~ 
fiixos~ 
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Masa~ Maed~ fJ~ma Hok~r, l~an Lowas, Ro,e~ D. l~s. 0 ~  o~ 
VAMecrc~C.emertnOUnimrs~o~Hea l th~ 
Cente~, Oenv~, CO. 
Melavtn~n is a card~ a~d smooth muscle spt~ i~ofonn of ~e cy. 
toskel~ ~tein vfnC~, wWch come~ ac~n f~urents to ttra ~,,-~/~,;.,,a 
in the cell. Metavincu~ c~ab~ a ~l a~.-,-~.-~ ~ exon ~-~ an 
~ ' ~  ~ ~r~,  ~dd~ near the C t~n~us o~ vinm~, and i~ Ioc~ to 
the ~ ~cs  and ~ of ~u~as mus~ an~ ~ v ~  ~s- 
so~a~ I~1~ tn smooth rnusde. ~n 1ms n~o~t ~ d~r~ a intent w~h 
kr, opae~c ~,a~e~ r~omyopa~ OOc) and ee~ence o~ ~=;,~c metav~ 
• ~,,n. Polyneraas cl~n rea~o~ (PCR) anatysts (~m~r, sa'-a~ a,~e~e of 
the ~ mRNA ~ isofOnn tn ca~c tissue from a s.qect 
in bo~ our 10C su~ ;~d co~I~o~, PCR of ~non~ DNA ~m the t~ 
sut~ demonslnm~ g~e pn~m(:e of an b~ct ~.~;~vlno~ exon~ West- 
ern bk~ a.alysls dem.s~ed abse~e of me~avlnct~ but r~ vd~rm in 
t~ue homogem~ from ~e IOC hea~ ~ of ~a~ v~t~n 
,~,-,~,~;.-~,~  inler~_.~ ~_~ disc s '~cm~ in our subi~ 
pared ~) thoas ~ ~ cor~ The ~ defi~ncy Zn 
t~s sul~ect e~as not amear to m se~- ,~y to a ~ process m 
~ed heart is~e. Tw~ty ek~t human he~'t ~ were an~yze~ 
fnclud~ mree ~;~ corroo~ rr~e ~ ~ ,  one X ~  
cass~mpamy, and n~ne~m s~s ,~th  k~c  d~ can~o~yo~ 
my. ~ ~ was orgy de.:ted in the one su~je~ des~bed 
In ~ re l~ C ,~ ~ of v i~  a~xl othe~ o m ~  pro~ 
asm:~eed w~h 10om the Z ~re~ (=-ace~), and the membm.e (d)~~.'~n) 
were nmmaL These results denM-., ; ,~ a deficlen~ f ~ mRNA 
and l~tein M a su l~ v~1 di~a~?~ c a n ~ ,  i ~  due to a 
defe~ in mRNA a]~-r~ve 
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Does ACE Genoq~3e influence the Oe~ent  of 
Left Ven~iculmr ~ in Untmm~l 
Jaw~ Ma~ Kevin P. J. O'Kase, Man~ Shahi, Mick/k. (~kor, ~ 
A. Johnszone, N~ FL Poefler, Pe~r S. Sew~, Rodrey A. Fo~. O;~d 
J. WOf~ S~non A, MeG. Thorn. St. Mary's Hospt~ ~ and Western 
The presenoe of LVH IXedCs an i~reased ~ ard mortat~ in P~ents 
with hyp,~,~,~,k,~;~',~ The ACE gene has been fouml ~ have 3 ~-,,~-ypes and 
the O all~e has Ixmn fom¢ to be ~ wi~ a r~.;;~- of caNtac 
~sease¢ Our hypolheds was that me ircrmsed pU,~v,~ ACE leve~ Pmse.t 
tn the DO genotype group m~ result in as increased tendmcy eo develop LVH 
either Gqm:~ or Incf~ectly ~a 1he ~ects of BI:'. We haw a,~,~;ed this issue 
Each genofype ~mu4p had similar ma~efleenmle ~ (1110/6, ID ~10,  DD 
14/7), agas (1147 :b 3, ID 48:1: 3, DD 47 :E 3 yearn), BP (11163 :b 4196 :E 
~. IO 167 ~ 4 /~I  ~ 2, DO 161 ::E 4 / 96 ~ 3 mmHo) and caxrlta~ stnx;tmal 
and ltjncfJonal pararrmtm's [~ft ~ mass ittdex ~VMI), It 136 -t" 9, ID 
132 ;:1: 7, DO 131 + 8 g~Z; E/A raZio, tl 1.07 ~ 0.t, IO 1,07 • 0,09, DD 
1.03 ::E 0.07; ISORdtlmic ~ t~ II 105:1: 7, IO IQ~I • 4, OD 97 :E 6 
ms]. In each group them m.s a significant relatiomh~ betwe~ syslolic BP 
and LVM] (II r :  0,SS, p ,= 0.02,10 r = 0.40. p = 0,02, DD r ~ OAg. P = 0. 0~ 
The ~emnce in ~tese corm~im~ tx~veen the 3 ~ gmq~s was not 
TNs woldd so~ 1hat AGE ge~ does not exe~ a large influence on 
